Company / Cash per Share
GeneDx Holdings Corp. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.75
FY2025
5-year range
$3.28 / $3230395.16
FY2021-FY2025
Trend
+14.3%
vs FY2024
Sector context
#65 of 150
Health Care
What the data says
At $3.75, GeneDx Holdings Corp.'s cash per share ranks #65 of 150 in the Health Care sector. Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $3.75.
Based on SEC 10-K filings.
3.75 in FY2025 with a 5-year CAGR of -82.2%.
Declined from $8.47 to $3.75 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -94.6%
- 5-Year CAGR
- -82.2%
- 10-Year CAGR
- -
Sector benchmark
#65 of 150 in Health CareTop 43% of 150This company $3.75 Sector average $27.11
▼
-86.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 14.3% year-over-year.
- Ranks #65 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.75 | +14.3% |
| FY2024 | $3.28 | -61.3% |
| FY2023 | $8.47 | -100.0% |
| FY2022 | $24153.77 | -99.3% |
| FY2021 | $3230395.16 | +15228.6% |
| FY2020 | $21074.25 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026